IOL Chemicals Joins 'Saksham Niveshak' Campaign to Facilitate Unclaimed Dividend Claims
IOL Chemicals has joined the 'Saksham Niveshak' campaign to help shareholders claim unpaid dividends from FY 2019-20 to FY 2025-26. Shareholders must update KYC details and submit required forms by July 9, 2026, to facilitate dividend claims and prevent transfer to IEPF. Physical shareholders contact RTA; Demat shareholders contact DP.
The announcement pertains to an investor awareness campaign focused on unclaimed dividends and KYC updates, which is a standard regulatory compliance activity and is unlikely to have a significant financial or operational impact on the company.
The announcement is a routine corporate communication about a government-led investor awareness campaign and does not contain any specific financial performance data or significant business updates that would warrant a positive or negative sentiment.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has joined the second 100-day "Saksham Niveshak" campaign, launched by the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs. This initiative, which commenced on April 1, 2026, aims to assist shareholders in claiming their unpaid or unclaimed dividends.
The company is reaching out to shareholders whose dividends remain unpaid or unclaimed, particularly for the financial years 2019-20 to 2025-26. The campaign also encourages shareholders to update their Know Your Customer (KYC) details, including PAN, bank mandates, email ID, and mobile numbers, to prevent their unclaimed dividends and corresponding shares from being transferred to the Investor Education and Protection Fund (IEPF).
Shareholders holding shares in physical form are advised to submit self-attested KYC documents and relevant forms (ISR-1, ISR-2, SH-13, ISR-3, SH-14) to the company's Registrar and Share Transfer Agent, Alankit Assignments Limited. Forms are available on the company's website. Shareholders with shares in demat form should contact their Depository Participants (DP) to update their KYC details. All dividend payments will be made via electronic mode, and service requests will be processed only after the receipt of necessary KYC documents. Shareholders are urged to submit their documents by July 9, 2026, to ensure timely credit of dividends and avoid transfer to IEPF. Details of unclaimed dividends are available on the company's website.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under other investor communications. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.